Home Health Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents
HealthNews

Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents

266

On Monday, the World Health Organisation (WHO) announced its approval of Bavarian Nordic’s Jynneos vaccine for adolescents aged 12 to 17. This group is considered particularly vulnerable to mpox outbreaks. The vaccine was prequalified by the WHO on October 8, 2024, following its earlier approval for adults.

The approval comes after the European Union authorised the vaccine for adolescents in September. The WHO declared mpox a global public health emergency in August, after a new strain of the virus spread across many countries.

Bavarian Nordic is set to begin clinical trials to assess the vaccine’s safety for children aged two to 12. The trials are expected to start in October. Meanwhile, the U.S. FDA has approved the vaccine for adults.

Another mpox vaccine, LC16, developed by Japan’s KM Biologics, is already approved for use in children but requires a specialised needle for administration.

Read More:

About The Author

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

FG Moves to Hike Electricity Tariff Despite Economic Hardship
News

Tinubu to Spend N10bn on Aso Villa Solar Project as Nigerians Struggle with Power Outages

The Federal Government has allocated N10 billion for a solar mini-grid at...

BusinessNews

33 West Africans Rescued from a Human Trafficking Scheme in Côte d’Ivoire

Police in Côte d’Ivoire have rescued 33 West Africans from a human...

NewsSecurity

Malian Army Intensifies Antiterror Strikes Near Algerian Border Following Algeria Escalation

The Malian Armed Forces (FAMa) have intensified their counter-terror operations near the...

NewsSecurity

Suspected Coup Plot in Burkina Faso: Several Military Officers Arrested

Authorities in Burkina Faso have reportedly arrested several military officers, including two...